United States · Bill · S
S. 3420 (115th)
Accountability in Opioid Advertising Act
Introduced
6 September 2018
Last action
—
Status
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Sponsors
—
Subjects
Discovery layer
Source updated
11 August 2025
Summary
Accountability in Opioid Advertising Act This bill requires the Food and Drug Administration to prioritize the review of advertising and other promotional materials for drug for serious, life-threatening diseases or conditions or substance use disorders, especially opioids (drugs with effects similar to opium, such as certain pain medications) and drugs used in the treatment of opioid use disorders.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in Senate (text)
Introduced in Senate · EN · 6 September 2018
Introduced in Senate (PDF)
Introduced in Senate · EN · 6 September 2018
Introduced in Senate
summary · EN · 6 September 2018
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/115th-congress/senate-bill/3420
- Open data entity: https://api.congress.gov/v3/bill/115/s/3420